Location preference

Enter your country so we can show you products that are available for you.

Product Security Updates

Product Security Bulletin for INFRA:HALT

03 September 2021

Background

Terumo Blood and Cell Technologies is aware of the INFRA:HALT global cybersecurity threat. Our internal teams are performing technical product assessments to determine any potential risks. We actively monitor our company’s internal Internet-connected devices, as well as the broader industry, for other possible cybersecurity vulnerabilities. Terumo Blood and Cell Technologies recommends that everyone in the global healthcare ecosystem employ industry-standard network security management and monitoring of their environments. Additional information will be posted on this page as it becomes available.

To top